Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients.
Memiş
D
D
Hekimoğlu
S
S
Vatan
I
I
Yandim
T
T
Yüksel
M
M
Süt
N
N
D016638:Critical Illness / Q000628:therapy; D020927:Dexmedetomidine / Q000494:pharmacology*; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D018836:Inflammation Mediators / Q000097:blood; D008874:Midazolam / Q000494:pharmacology*; D018805:Sepsis / Q000628:therapy*
D006993:Hypnotics and Sedatives; D018836:Inflammation Mediators; D020927:Dexmedetomidine; D008874:Midazolam